Optimal Dose of Misoprostol combined with Oxytocin for Preventing Postpartum Hemorrhage in Cesarean Sectio

Phase 2

Completed

• Conditions: Postpartum hemorrhage; Misoprostal; Oxytocin; Blood loss; cesarean section

• Registration Number: TCTR20211102001
• Lead Sponsor: Phayao Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-08-07
• Study Start: 2021-11-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 333

Inclusion Criteria

inpatient department of OB-GYN unit who indicated for cesarean section.

Exclusion Criteria

Our patients no contraindication for administrated misoprostol
The patient who reported co-morbid diseases of bleeding tendency

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood loss immediate postoperative estimate blood loss

Secondary Outcome Measures

Name	Time	Method
Side effect of misoprostol within 24 hours post operative Clinical sign and symptom